These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33447611)

  • 41. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchial hyper-responsiveness and exhaled nitric oxide in chronic obstructive pulmonary disease.
    Schafroth Török S; Leuppi JD
    Swiss Med Wkly; 2007 Jul; 137(27-28):385-91. PubMed ID: 17705099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
    Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
    J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
    Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
    Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-Time Breath Analysis Reveals Specific Metabolic Signatures of COPD Exacerbations.
    Gaugg MT; Nussbaumer-Ochsner Y; Bregy L; Engler A; Stebler N; Gaisl T; Bruderer T; Nowak N; Sinues P; Zenobi R; Kohler M
    Chest; 2019 Aug; 156(2):269-276. PubMed ID: 30685334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detecting Pulmonary Oxygen Toxicity Using eNose Technology and Associations between Electronic Nose and Gas Chromatography-Mass Spectrometry Data.
    Wingelaar TT; Brinkman P; de Vries R; van Ooij PAM; Hoencamp R; Maitland-van der Zee AH; Hollmann MW; van Hulst RA
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31766640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.
    Brekelmans MP; Fens N; Brinkman P; Bos LD; Sterk PJ; Tak PP; Gerlag DM
    PLoS One; 2016; 11(3):e0151715. PubMed ID: 26982569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
    Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
    Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the COPD Assessment Test respiratory item score on the decision to hospitalize patients with disease exacerbation in a hospital emergency department.
    Pulido Herrero E; Villanueva Etxebarria A; Aramburu Ojembarrena A; Piñera Salmerón P; Quintana López JM; Esteban González C; Gallardo Rebollal MS; Amigo Angulo JM; Urrutikoetxea Etxebarria S; Ibarrola Luengas I; Armentia Bardeci JM; García Gutiérrez S
    Emergencias; 2022 Apr; 34(2):95-102. PubMed ID: 35275459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An electronic nose may sniff out amyotrophic lateral sclerosis.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Marra L; D'Alba G; Resta O
    Respir Physiol Neurobiol; 2016 Oct; 232():22-5. PubMed ID: 27343949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset.
    Calverley PMA; Papi A; Page C; Rogliani P; Dal Negro RW; Cazzola M; Cicero AF; Wedzicha JA
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1909-1920. PubMed ID: 36034589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exhaled Breath Analysis Detects the Clearance of
    Seidl E; Licht JC; de Vries R; Ratjen F; Grasemann H
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human volatilome analysis using eNose to assess uncontrolled asthma in a clinical setting.
    Farraia M; Cavaleiro Rufo J; Paciência I; Castro Mendes F; Rodolfo A; Rama T; Rocha SM; Delgado L; Brinkman P; Moreira A
    Allergy; 2020 Jul; 75(7):1630-1639. PubMed ID: 31997360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study.
    Basanta M; Ibrahim B; Dockry R; Douce D; Morris M; Singh D; Woodcock A; Fowler SJ
    Respir Res; 2012 Aug; 13(1):72. PubMed ID: 22916684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.